Wegovy and Ozempic (semaglutide) in Hyderabad β one ingredient, different medicines.
Wegovy, Ozempic and Rybelsus all contain semaglutide, but they are not interchangeable. A LIFE doctor reviews your health first and then decides whether any of them β or none β is appropriate.
Wegovy β a once-weekly semaglutide injection made for long-term weight management in suitable adults.
Ozempic β a once-weekly semaglutide injection made for type 2 diabetes.
Rybelsus β a semaglutide tablet taken daily, made for type 2 diabetes.
Sharing an ingredient does not make the brands the same. The strengths, the pens, the approved uses and the way the dose is built up are different. Other semaglutide brands may also be sold in India; your doctor confirms what is approved and suitable at consultation.
How semaglutide works
It copies the action of GLP-1, a hormone the gut releases after eating.
It reduces appetite and helps you feel full for longer.
It slows how quickly the stomach empties.
In type 2 diabetes it supports the bodyβs insulin response after meals.
How it is taken
The injections are taken once a week. Treatment starts at a low strength and the prescriber raises it gradually over several months, watching how you tolerate each step. The tablet form is taken daily on an empty stomach, as the doctor instructs.
Never switch between brands, or between injection and tablet, on your own. The doses do not convert one-to-one.
Who a doctor may consider it for
Adults living with obesity, after a medical assessment.
Adults who are overweight with a weight-related health condition.
Adults with type 2 diabetes, where the treating doctor finds a semaglutide medicine appropriate.
People prepared for nutrition and activity changes alongside the medicine.
Who needs extra caution
Anyone who is pregnant, breastfeeding or planning a pregnancy.
People with a personal or family history of medullary thyroid cancer or MEN 2 syndrome.
People who have had pancreatitis or gallbladder disease.
People with diabetic eye disease (retinopathy) β tell the doctor, as it needs monitoring.
People on insulin or sulfonylurea tablets, because blood sugar can drop too low without a dose review.
How LIFE handles a semaglutide enquiry
LIFE starts with assessment, not a brand. A doctor reviews your history, medicines and relevant reports, explains benefits, risks and alternatives, and decides what β if anything β to prescribe.
A prescription comes with a clinical diet plan, protein and hydration guidance, activity support to protect muscle, tolerance checks and scheduled reviews. Medicine is supplied only against a valid prescription through a licensed pharmacy.
YOUR QUESTIONS
Frequently asked
Short, honest answers. Your own situation is always decided with the doctor at consultation.
Ozempic is a type 2 diabetes medicine. Wegovy is the semaglutide brand made for weight management. Which medicine is appropriate for you is the doctorβs decision after assessment.
Can I switch from Ozempic to Wegovy, or to Mounjaro?+
Only if your prescriber decides so. The doses do not convert directly between brands or between semaglutide and tirzepatide, so a switch is planned and monitored by the doctor.
Can I buy Wegovy or Ozempic from LIFE without a consultation?+
No. These are prescription medicines. LIFE does not supply them without a doctorβs assessment and a valid prescription.
Is the semaglutide tablet as good as the injection?+
They are different formulations used for specific approved purposes and are not interchangeable. The doctor chooses the form that fits your clinical need.
What happens if I stop semaglutide?+
Appetite usually returns and weight can come back. Stopping or reducing is planned with the prescriber, with a food and activity maintenance plan in place.
MORE GLP-1 GUIDES
Keep reading, then talk to a doctor.
Each guide answers one question about GLP-1 medicines in plain language.
Select your nearest LIFE branch. Our team will call, understand your health goals and arrange a doctor-led assessment.
11 clinic locationsDoctor-led assessmentSent securely to LIFE
This page provides general education and does not advertise or guarantee access to a specific prescription product. Brand names are the property of their respective owners. GLP-1 and related medicines are not suitable for everyone and may cause side effects, including uncommon serious risks. Eligibility, medicine selection, dose, monitoring and duration must be decided by a qualified medical professional. Do not change medicines without the prescriber. Individual outcomes vary.